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Abstract
Background: Societal costs of low back pain (LBP) are high, yet few studies have 
been performed to identify the predictive factors of high societal costs among chronic 
LBP patients. This study aimed to determine which factors predict high societal costs 
in patients with chronic LBP.
Methods: Data of 6,316 chronic LBP patients were used. In the main analysis, high 
societal costs were defined as patients in the top 10% of cost outcomes. Sensitivity 
analyses were conducted using patients in the top 5% and top 20% of societal costs. 
Potential predictive factors included patient expectations, demographic factors (e.g. 
age, gender, nationality), socio‐economic factors (e.g. employment, education level) 
and health‐related factors (e.g. body mass index [BMI], general health, mental 
health). The final prediction models were obtained using backward selection. The 
model's prognostic accuracy (Hosmer–Lemeshow X2, Nagelkerke's R2) and discrimi-
native ability (area under the receiver operating curve [AUC]) were assessed, and the 
models were internally validated using bootstrapping.
Results: Poor physical health, high functional disability, low health‐related quality 
of life, high impact of pain experience, non‐Dutch nationality and decreasing pain 
were found to be predictive of high societal costs in all models, and were therefore 
considered robust. After internal validation, the models' fit was good, their explained 
variance was relatively low (≤14.1%) and their AUCs could be interpreted as moder-
ate (≥0.71).
Conclusion: Future studies should focus on understanding the mechanisms associ-
ated with the identified predictors for high societal costs in order to design effective 
cost reduction initiatives.
Significance: Identifying low back pain patients who are at risk (risk stratification) 
of becoming high‐cost users and making appropriate initiatives could help in reduc-
ing high costs.
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1 |  INTRODUCTION
In recent years, low back pain (LBP) has become the leading 
cause of years lived with disability in high‐, middle‐ and low‐
income countries (Vos et al., 2017) A 54% increase in years 
lived with disability caused by LBP was reported worldwide 
between 1990 and 2015 (Hartvigsen, Hancock, & Kongsted, 
2018) Next to the high disease burden of LBP, its economic 
burden is substantial (Tulder, Koes, & Bombardier, 2002) In 
2007, for example, the societal cost of LBP in the Netherlands 
was estimated to be 3.5 billion euros, which accounted for 
approximately 0.6% of the Gross National Product (Lambeek 
et al., 2011). The estimated annual total cost of LBP in the 
United States is 100 billion dollars, (Dieleman et al., 2016) 
in Australia 9 billion Australian dollars, (Walker, Muller, & 
Grant, 2003) in Switzerland 6.6 billion euros (Wieser et al., 
2011) and in the UK 12.3 billion British pounds (Maniadakis 
& Gray, 2000).
A systematic review by Hestbaek, Leboeuf‐Yde, and 
Manniche (2003) showed that in many cases LBP did not re-
solve on its own and that 62% of LBP patients keep experi-
encing pain after 12 months.(Hestbaek et al., 2003; Verkerk 
et al., 2013) Nonetheless, the majority of LBP patients do not 
seek treatment (Ferreira et al., 2010) and Engel, Von Korff, 
and Katon (1996) and Vlaeyen et al. (2018) reported that it 
is very likely that the majority of the total societal costs from 
LBP stem from a relatively small group of chronic LBP pa-
tients (Engel et al., 1996; Vlaeyen et al., 2018).
A proactive approach requires identifying high‐risk pa-
tients accurately before substantial avoidable costs have been 
incurred and health status has deteriorated. Exploring the 
mechanisms related to high‐cost users could potentially lead 
to ideas for initiatives or policy measures aimed at reducing 
costs. A report from The Commonwealth Fund (2012) main-
tains this view by placing emphasis on the need to address 
high‐cost health care users with chronic conditions if poten-
tially significant gains are to be made (System TCFCoaHPH, 
2012). Identifying factors predictive of high societal costs 
may provide opportunities to create appropriate initiatives 
aiming to prevent high‐cost outcomes as well as result in im-
provement of patient quality of life and a reduction in health 
care spending (Buchbinder et al., 2013; Chechulin, Nazerian, 
Rais, & Malikov, 2014).
To date, many studies have focused on investigating fac-
tors that predict whether acute LBP will become chronic. 
Various studies have identified a number of predictive fac-
tors for LBP chronicity, including high levels of psycho-
logical distress, low levels of physical activity, smoking, 
poor self‐rated health and dissatisfaction with employment 
(Klenerman, Slade, & Stanley, 1995; Linton & Halldén, 
1998; Valat, Goupille, & Védere, 1997). However, in prac-
tice there is limited success in using this information to pre-
vent or manage chronic LBP (Tulder et al., 2002; Waddell, 
2006). Furthermore, whilst predictive factors have com-
monly been investigated in various other areas of LBP, such 
as identifying predictive factors for return to work, disability 
and future health care utilization, few studies have explored 
the possible factors that are predictive of high societal cost 
(Becker et al., 2010; Lancourt & Kettelhut, 1992; Pincus, 
Burton, Vogel, & Field, 2002; Skargren & Öberg, 1998). 
Therefore, the aim of this study was to identify predictive 
factors for high societal costs among chronic LBP patients 
in the Netherlands.
2 |  METHODS
2.1 | Study population and design
A model was constructed to determine factors predicting 
high societal costs among chronic LBP patients. Data col-
lected during the MinT (minimal invasive treatment) study 
in the Netherlands were used to develop the model. The 
MinT study consisted of three randomized controlled tri-
als and an observational study. The aim of the MinT study 
was to assess the cost‐effectiveness of adding minimal in-
terventional procedures to a standardized exercise program, 
compared with a standardized exercise program alone (Juch 
et al., 2017; Maas et al., 2012). Patients were eligible for 
the MinT study in general if they had chronic (>3 months) 
LBP, showed no improvement of symptoms after conserva-
tive treatment, were referred to a pain clinic and were able 
to complete Dutch questionnaires. Patients were included 
in the randomized controlled trials and observational study 
between 1 January 2013 and 1 July 2014 and between 1 
January 2013 and 17 December 2015, respectively. In the 
present study, only data of the observational study were 
used. The observational study monitored patients who did 
not want to, or were not eligible to participate in the afore-
mentioned randomized controlled trials or who received the 
intervention after recruitment for the randomized controlled 
trials was closed (between 1 July 2014 and 17 December 
2015) (Maas et al., 2012). The exclusion criteria for partici-
pating in the randomized controlled trials included, amongst 
others, patients with a negative diagnostic test, patients with 
a body mass index (BMI) higher than 35, patients older than 
70 years, patients with severe psychiatric or psychological 
problems, patients diagnosed with facet, disc, sacroiliac (SI) 
joint or combination pain but did not want to participate in 
the randomized controlled trials (Maas et al., 2012). The ob-
servational data will inform about the proportion of patients 
with a positive or negative diagnostic test for facet pain, 
disc pain, SI joint pain and a combination of these, and the 
clinical outcomes of patients with a negative diagnostic test. 
Patients diagnosed with facet, disc, SI joint or combination 
pain, by means of a diagnostic block, will be asked to take 
part of one of the four RCTs. The observational study will 
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monitor patients who do not want to, or are not eligible to 
participate in the RCTs.
Ethical approval for the MinT study was obtained from the 
Medical Ethics Committee of the Erasmus Medical Centre in 
Rotterdam (registration number MEC‐2012–079). Local re-
search governance was obtained from all participating pain 
clinics and all participants gave written informed consent 
(Maas et al., 2012).
2.2 | Outcome measure
The outcome of the current study was having high societal 
costs (yes/no). Having high societal costs was defined as pa-
tients with costs in the top 10th percentile. Previous studies 
have defined high costs as patients in the top 20–25th per-
centile (Becker et al., 2010; Engel et al., 1996). A study in 
the United States studied health care expenditures from 1928 
to 1996 found that the top 5% of high‐cost users accounted 
for more than half of health spending, while the top 10% ac-
counted for about 70% of all health care spending (Berk & 
Monheit, 2001). For this study, the 10th percentile for soci-
etal costs was therefore assumed to be appropriate due to the 
large sample size.
Societal costs were measured using 3‐monthly retrospec-
tive cost questionnaires throughout the 1‐year study period 
(i.e. administered at 3‐, 6‐, 9‐ and 12‐month follow‐up; 
Goossens, Rutten‐van Mölken, Vlaeyen, & Linden, 2000). 
The self‐administered cost questionnaires included measures 
of health care utilization, informal care, unpaid productivity 
and absenteeism due to back pain. Health care utilization in-
cluded primary care (e.g. general practitioner care, manual 
therapy, physical therapy, exercise therapy) and secondary 
care (e.g. diagnostic and therapeutic interventions, hospi-
talization). Data from the updated Dutch Manual of Costing 
were used to value costs of common health care services 
(Hakkaart‐van Roijen, Van der Linden, Bouwmans, Kanters, 
& Tan, 2015). For less common health care services, hospital 
accounting records and/or prices of professional organiza-
tions were used. Informal care and unpaid productivity were 
valued using the recommended Dutch shadow price of €14,32 
per hour (Hakkaart‐van Roijen et al., 2015). Absenteeism 
from paid employment was measured using the Productivity 
and Disease Questionnaire (PRODISQ; Koopmanschap, 
2005), and was valued in accordance with the friction cost 
approach using hourly productivity costs of males and fe-
males (Koopmanschap & Rutten, 1996). The friction cost 
approach assumes that production losses are confined to the 
period needed to replace a sick worker, which is currently 
assumed to be 12  weeks in the Netherlands (Hakkaart‐van 
Roijen et al., 2015). All costs were expressed in Euros 2017. 
An overview of the main cost categories, examples of com-
mon sub‐cost categories as well as their unit prices can be 
found in File S1.
2.3 | Potential predictive factors
Potential predictive factors were based on previous litera-
ture (Becker et al., 2010; Chechulin et al., 2014; Engel et al., 
1996; Klenerman et al., 1995; Lancourt & Kettelhut, 1992; 
Linton & Halldén, 1998; Pincus et al., 2002; Skargren & 
Öberg, 1998; Valat et al., 1997), and measured at baseline 
and included:
• Treatment credibility and patient expectancy for im-
provement after treatment (Credibility/Expectancy 
Questionnaire [CEQ] (Devilly & Borkovec, 2000); scores 
were transformed to 0—least credibility/expectancy to 
100—more credibility/expectancy) to improve compara-
bility of the odds ratios.
• Pain intensity (Numeric Pain Rating Scale [NPRS]; range 
0—no pain to 100—worst pain imaginable; Childs, Piva, 
& Fritz, 2005). Scores were transformed to 0–100 to im-
prove comparability of the odds ratios.
• Functional disability (Oswestry Disability Index [ODI]; 
range 0—no disability to 100—maximum disability; 
Davidson & Keating, 2005; Fairbank & Pynsent, 2000).
• Health‐related quality of life (EuroQol [EQ‐5D‐3L]; range 
0—worst imaginable health state to 100—best imaginable 
health state, higher scores indicating better health; Rabin, 
2001). The participants' EQ‐5D‐3L scores were con-
verted into utility scores using the Dutch tariff (Lamers, 
Stalmeier, McDonnell, & Krabbe, 2005) and the scores 
were transformed to 0–100 to improve comparability of the 
odds ratios.
• General health—mental component score and physical 
component score (Rand‐36 [Rand‐36]; scores range 0—
lowest general health to 100—highest general health) were 
transformed so that a higher score indicated better health 
status (Brazier et al., 1992; Hays & Morales, 2001; Vander 
Zee & Sanderman, 1996). The two dimensions of the 
Rand‐36 form, namely mental and physical health, were 
entered separately in the model.
• Impact of pain experience (Multidimensional Pain 
Inventory [MPI]; range 0—least/best to 100 most/worst). 
Scores were transformed to 0–100 to improve compara-
bility of the odds ratios. For the purpose of this analysis, 
scores from the five sub‐scales of the first section of the 
MPI were used, that is, pain severity, interference with 
daily activities, life control, affective distress and support 
(Lousberg et al., 1999; McKillop & Nielson, 2011).
• Education level low/moderate/high. Low indicates no ed-
ucation, primary level education, lower vocational and 
lower secondary education; moderate indicates higher sec-
ondary education or undergraduate; high indicates tertiary 
education, university or postgraduate.
• Body mass index ([BMI], weight in kg/(height in metres)2).
• Employment (yes/no).
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• Recurrent complaints (yes/no).
• Age in (years).
• Gender (male/female).
• Nationality (Dutch/non‐Dutch).
• Smoking (yes/no).
• Type of health care insurance (basic/additional).
• Region of residence (south/north/east/west).
• Married/living together (yes/no).
• Diagnosis (sacroiliac joint (SI)/facet/disc/combined/un-
clear). Diagnosis was based on medical history and clin-
ical examination. Both followed a standard format and 
were performed by experienced clinicians. Depending 
on the suspected source of pain, clinical examination in-
cluded provocation tests (compression test; distraction test; 
Flexion, Abduction, and External Rotation [FABER] test; 
Gaenslen test; thigh thrust test; Gillett test) and diagnos-
tic anaesthetic blocks. For a more detailed description of 
the diagnostic procedures, we refer elsewhere (Juch et al., 
2017; Maas et al., 2012).
2.4 | Statistical analysis
The prediction model was constructed using multivariable 
logistic regression analysis (Harrell, Lee, & Mark, 1996; 
Steyerberg, 2010). Prior to constructing the model, missing 
data were handled using multiple imputation to avoid possi-
ble bias due to selective drop‐out of participants, which might 
influence the results when conducting a complete‐case analy-
sis (Burton, Billingham, & Bryan, 2007). Imputations were 
performed by treatment group and per time point using pre-
dictive mean matching. Following this, tests were conducted 
to verify the linearity and additivity assumptions (Harrell et 
al., 1996).
Manual backward selection was used to obtain the final pre-
dictive factors with a p < .10. Variables with the highest p‐value 
were excluded from the model one by one and the analysis was 
rerun until only variables with a p < .10 constituted the model. 
A p  <  .10 was used to ensure that predictions are accurate, 
whilst preventing type‐1 errors caused by overfitting (Harrell 
et al., 1996). The overall performance and predictability of the 
model were tested using Nagelkerke's R2 (Bewick, Cheek, & 
Ball, 2005; Greiner, Pfeiffer, & Smith, 2000; Steyerberg et al., 
2010). Other performance measures included the area under 
the “receiver operating characteristics” (ROC) curve to mea-
sure the final model's discriminative value (area under the re-
ceiver operating curve [AUC]) (Bewick et al., 2005; Greiner 
et al., 2000; Steyerberg et al., 2010) as well as the Hosmer–
Lemeshow goodness‐of‐fit to measure the calibration of the 
model (Bewick et al., 2005; Greiner et al., 2000; Steyerberg et 
al., 2010). To adjust for the fact that the model was developed 
and tested in the same population, which typically causes re-
gression coefficients and performance measures to be overes-
timated (i.e. overfitting), bootstrapping was used to internally 
validate the model (Bewick et al., 2005; Greiner et al., 2000; 
Steyerberg et al., 2010). Multiple imputation and multivariate 
regression analyses were conducted using Stata (version 14SE, 
Stata Corp), and internal validation was performed using R 
(i386 version 3.1.2).
To test the robustness of the results, two sensitivity analy-
ses were conducted; (a) using the top 20th percentile for high 
costs, and (b) using the top 5th percentile for high costs.
3 |  RESULTS
3.1 | Participants
Data from 6,316 chronic LBP patients in the observational 
study group were analysed in the present study (Figure 
1). Of them, the majority were female (66%), overweight 
(67%), Dutch (95%), had a low level of education (56%) 
and more than half were unemployed (59%; Table 1). Most 
of the predictive factors had about 17% of patients with 
missing data. The amount of missing values for all the vari-
ables entered in the model are reported in File S2. Costs at 
different cut‐off points were as follows: 10% (≥€11,922), 
5% (≥€19,403) and 20% (≥€7,906). The average societal 
costs per patient were €5,522 and the median costs were 
€2,995.
3.2 | Development, 
performance and internal validity of the top 
10% prediction model
Females, non‐Dutch nationals, combined diagnosis (LBP 
caused by both facet joints and intervertebral disc), poor 
physical health, high functional disability, low health‐related 
quality of life, decreasing age, high impact of pain experi-
ence and decreasing pain intensity were found to increase the 
odds of having high societal costs (Table 2). The Hosmer–
Lemeshow statistic was not significant (X2  =  7, p  =  .55), 
indicating that the model's overall fit was good. The model 
explained 14.3% (Nagelkerke's R2) of the variation in the out-
come (i.e. high societal costs) and the model's AUC was 0.74 
(95% CI 0.67–0.72). After internal validation, the model's ex-
plained variance was 13.2% and the AUC was 0.73. The cali-
bration slope was 0.97, indicating relatively little optimism 
or overfitting of the regression coefficients.
3.3 | Sensitivity analysis
Using an outcome consisting of patients in the top 20th per-
centile of societal costs, combined diagnosis, poor physical 
health, high functional disability, low health‐related quality 
of life, high impact of pain experience, non‐Dutch nation-
ality, decreasing pain intensity and being female were pre-
dictive factors of having high societal costs (Table 3). The 
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Hosmer–Lemeshow statistic was not significant (X2=  8.5, 
p =  .47), Nagelkerke's R2 was 0.146 and the model's AUC 
was 0.72. After internal validation, the model's explained 
variance reduced to 14.1% and the AUC to 0.71. The calibra-
tion slope was 0.98.
Using an outcome consisting of patients in the top 5th per-
centile of societal costs, high‐level education, poor physical 
health, high functional disability, low health‐related quality 
of life, high impact of pain experience, non‐Dutch national-
ity and decreasing pain intensity were predictive factors of 
having high societal costs (Table 4). The Hosmer–Lemeshow 
statistic was not significant (X2 = 7.2, p = .59), indicating that 
the model's overall fit was good. The model explained 14.1% 
(Nagelkerke's R2) of the variation in the outcome (high costs) 
and the model's AUC was 0.76. After internal validation, the 
model's explained variance reduced to 13.2% and the AUC to 
0.76. The calibration slope was 0.97.
Table 5 provides an overview of robust predictors of high 
societal costs in all three models
4 |  DISCUSSION
4.1 | Main findings
High impact of pain experience (MPI interference), being fe-
male, non‐Dutch national, combined diagnosis (LBP caused 
by both facet joints and intervertebral disc), poor physical 
health, high functional disability, low health‐related quality 
of life, younger age and decreasing pain intensity were found 
to increase the odds of having high societal costs. The model's 
overall fit was good and its explained variance was relatively 
low (Bewick et al., 2005; Greiner et al., 2000; Steyerberg et 
al., 2010; that is, only 14.3% of the variance in high societal 
costs was explained by the identified predictive factors). The 
AUC was 0.73 and can be interpreted as moderate (Greiner et 
al., 2000). Internal validation had little effect on the model's 
performance, illustrating minimal chance of overfitting of the 
regression coefficients (Steyerberg et al., 2010).
At a 5% cut‐off point in our sensitivity analysis, high ed-
ucation level became a predictor and gender and age were 
no longer predictors. There were no additional predictive 
factors when a cut‐off point of 20% was used, instead age 
was no longer a predictor. The performance of the sensitivity 
analyses models was equal to that of the main analysis. Poor 
physical health, high functional disability, low health‐related 
quality of life, high impact of pain experience, non‐Dutch na-
tionality and decreasing pain were found to be predictive of 
having high societal costs in all models, suggesting that they 
constitute the most robust predictors of high societal costs.
4.2 | Comparison with literature
Few studies have focused on investigating predictive fac-
tors for high societal costs among chronic LBP patients. 
A study by Engel et al. (1996) reported increasing chronic 
pain grade and pain persistence as strong predictors of high 
F I G U R E  1  Inclusion and exclusion of participants
12,985 Patients assessed for eligibility
5,424 Patients asked to participate in 1 of the RCTs5,168 Patients directly included in the observational study
2,133 Asked to participate in the 
Facet joint RCT
2,498 Asked to participate in the 
Sacroiliac RCT
793 Asked to participate in the 
Combination RCT
1,822 Excluded
1,202 Declined participation
259 Negative diagnostic 
facet joint block
277     Psychological problems
53 BMI > 35
95       Aged > 70 
2,770 Excluded
1,660 Declined participation
202 Negative diagnostic     
sacroiliac joint block
257     Psychological problems
47 BMI > 35
83        Aged > 70 y
15        Other 
591 Excluded
257  Psychological problems
52 BMI > 35
102  Aged > 70 y
139  Other 
6,319 Patients included in the current analyses
1,211 Patients excluded who did not 
provide informal consent
2,133 Patients willing to participate in the observational study
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T A B L E  1  Patients' characteristics, all patients and according to societal costs (high vs. low)
Participant characteristic
All patients 
(n = 6,316) High costs (n = 171)
Low costs 
(n = 6,145)
Age (years) [mean (SD)] 57.2 (13,4) 57.6 (12.0) 57.2 (13.5)
Gender (n, %)
Female 4,142 (66) 128 (75) 4,014 (66)
Male 2,093 (34) 43 (25) 2,050 (34)
BMI (n, %)
BMI < 18.5 (underweight) 37 (1)   37 (1)
BMI ≥ 18.5 < 25 (normal weight) 1,687 (32) 42 (26) 1,645 (32)
BMI ≤ 25 <30 (overweight) 2,060 (39) 62 (38) 1,998 (39)
BMI ≥ 30 (obese) 1,463 (28) 60 (37) 1,403 (28)
Smoking (n, %)
Yes 1,413 (26) 42 (25) 1,371 (26)
No 3,920 (73) 125 (75) 3,795 (73)
Educational level (n, %)
Low (no education, primary level education, lower vocational and lower 
secondary education)
2,925 (56) 100 (62) 2,825 (56)
Moderate (higher secondary education or undergraduate) 1,467 (28) 43 (27) 1,424 (28)
High (tertiary, university level, postgraduate) 830 (16) 19 (12) 811 (16)
Living together with a partner (n, %)
Yes 4,663 (75) 135 (79) 4,528 (74)
No 1,593 (26) 36 (21) 1557 (26)
Nationality (n, %)
Dutch 5,049 (95) 163 (98) 4,886 (95)
Non‐Dutch: 278(5.2) 4(2.8) 274(5.3)
Surinamese 21 (0.4) 0 21 (0.4)
Antillean/Aruban 22 (0.4) 0 22 (0.4)
Turkish 63 (1) 1 (1) 62 (1)
Moroccan 42 (1) 0 42 (1)
Other 130 (2.4) 3 (1.8) 127 (2.5)
Region in the Netherlands (n, %)
South 2,029 (32) 59 (35) 1,970 (32)
North 1,165 (19) 30 (18) 1,135 (19)
East 1,280 (20) 43 (25) 1,237 (20)
West 1782 (28) 39 (23) 1743 (29)
Employment (n, %)
Yes 1,687(42) 66 (39) 1,621 (42)
No 2,376 (59) 105 (61) 2,271 (58)
Recurrent low back pain (n, %)
Yes 3,174 (63) 101 (62) 3,073 (63)
No 1876 (37) 61 (38) 1815 (37)
Diagnosis‐source of pain (n, %)
1 = SI 1,864 (33) 57(36) 1,807 (33)
2 = Facet 2,269 (41) 54 (34) 2,215 (41)
3 = Disc 18 (0.3) 1 (0.63) 17 (0.3)
(Continues)
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costs and high back pain costs, followed by disc disorder/
sciatica diagnosis and increasing depressive symptoms. 
Diagnosis as a predictor of high costs is in line with the 
results of the present study as well as those of previous 
ones (Becker et al., 2010; Wenig, Schmidt, Kohlmann, & 
Schweikert, 2009). In contrast to the present study, they 
found mental health and high pain scores to be predic-
tors for high costs. Mental health was also a predictor of 
high societal costs in the studies of Becker et al. (2010) 
and Ritzwoller, Crounse, Shetterly, and Rublee (2006). 
This discrepancy could be due to different cut‐off points 
for high costs (>20% in the previous studies vs. 10% in 
the present study). The definition of mental health (i.e. de-
pression vs. general mental health) varied among the stud-
ies, Becker et al. (2010) focused on depression, whereas 
Ritzwoller et al. (2006) included anxiety, depression and 
psychosis. Differences in measuring mental health were 
noted, 1‐item question (present study) versus a risk adjust-
ment system used to identify comorbidities (Ritzwoller et 
al., 2006) versus CES‐D ranging from 0 to 60 (Becker et 
al., 2010). Depression was associated with high health care 
costs in the study of Becker et al. (2010) and a possible 
explanation was that physicians initiate costly health care 
when confronted with mood disorders (Becker et al., 2010). 
Ritzwoller et al. (2006) reported an association of depres-
sion and psychopathy with increased LBP episodes and 
high costs. Comorbidities have been associated with longer 
duration of LBP and work disabilities (Nordin et al., 2002).
Although previous studies have reported an increase in 
LBP intensity to be a predictor of high costs (Becker et al., 
2010; Wenig et al., 2009), the present study reported de-
creasing pain intensity as a predictor of high costs. A pos-
sible explanation for this discrepancy is that only chronic 
LBP was included in the present study versus general LBP 
(acute and chronic; Becker et al., 2010; Ekman, Jönhagen, 
Hunsche, & Jönsson, 2005; Engel et al., 1996; Ritzwoller et 
al., 2006; Wenig et al., 2009) and that the studies took place 
in different health care settings, that is, primary (Becker et 
al., 2010; Ekman et al., 2005; Engel et al., 1996; Ritzwoller 
et al., 2006) versus secondary (present study). Fink‐Miller, 
Long, and Gross (2014) reported that chronic LBP patients in 
primary care reported more severe pain compared to chronic 
LBP patients in tertiary care and suggest shorter duration of 
complaints and shopping for opioids by chronic LBP patients 
Participant characteristic
All patients 
(n = 6,316) High costs (n = 171)
Low costs 
(n = 6,145)
4 = Combined 1,391 (25) 44 (28) 1,347 (25)
5 = Unclear 66 (1) 3 (2) 63 (1)
Patients expectations
Credibility [mean (SD)] range 0–100 77.1 (17.5) 77 (19.1) 77.1 (17.3)
Expectancy [mean (SD)] range 0–100 57.8 (17.3) 57.2 (17) 58 (17)
Rand − 36
Mental [mean (SD)] range 0–100 22.6 (5) 21.6 (5) 22.6 (5)
Physical [mean (SD)] range 0–100 18.5 (4) 16.0 (4) 18.6 (4)
Health‐related quality of life(utility) [mean (SD)] range 0–100 48 (29) 31 (28) 48 (29)
MPI [mean (SD)] range per subscale 0–100
Pain severity 22.6 (5.7) 25.4 (4.4) 22.5 (5.7)
Interference with daily activities 5.8 (1.9) 6.9 (1.6) 5.8 (1.9)
Life control 21.2 (6.3) 20.2 (7) 21.2 (6.2)
Affective distress 15.4 (4.6) 16.5 (4.9) 15.3 (4.6)
Support 28.6 (7.6) 30.4 (6.2) 28.4 (7.6)
Type of health care insurance (n, %)
Basic insurance 633 (12) 14 (8) 619 (12)
Comprehensive (basic + additional cover) 4,630 (86) 153 (92) 4,477 (86)
I don't know 55 (1) 0 55 (1)
ODI functional disability [mean (SD)] range 0–100 11.1 (9) 17.1 (10) 11.1 (9)
Pain intensity [mean (SD)] range 0–100 73 (16) 77 (14) 73 (16)
Note: Percentages have been rounded off hence values a bit less than 100% and a bit more that 100%. Scores for MPI, Rand 36, patient expectations, health‐related 
quality of life were transformed to a range of 0–100 to enable comparability with the odds ratio. Diagnosis was based on patient history and physical examination.
Abbreviations: MPI, multidimensional pain inventory; ODI, oswestry disability index.
T A B L E  1  (Continued)
8 |   MUTUBUKI eT al.
in primary care as possible explanations (Fink‐Miller et al., 
2014). Also, patients presenting in secondary and/or tertiary 
care may have exhausted conservative therapies, hence could 
have already made high costs.
Contrary to the findings of Wenig et al. (2009), being fe-
male was a predictor of high costs in the present study and 
in previous studies (Ekman et al., 2005). Wenig et al. (2009) 
reported that women had a higher probability to cause high 
T A B L E  2  Multivariate model using the top 10th percentile of societal costs as an outcome
 
Coefficient 
(regression)a
SE (of regres-
sion coefficient) p‐value
95% CI
Lower bound Odds ratio Upper bound
Diagnosis (ref: sacroiliac joint)
Facet 0.097 0.139 0.487 0.836 1.102 1.452
Disc 0.109 0.983 0.912 0.161 1.115 7.744
Combined 0.263 0.142 0.066 0.982 1.301 1.725
Unclear 0.731 0.442 0.100 0.868 2.077 4.972
Physical health (Rand − 36); range 
0–100
−0.069 0.021 0.002 0.895 0.933 0.973
Functional disability (ODI); range 
0–100
0.035 0.008 0.000 1.019 1.036 1.053
Health‐related quality of life 
(EQ−5D−3L); range 0–100
−0.006 0.029 0.052 0.989 0.994 1.000
Impact of pain experience (MPI inter-
ference) range 0 − 100
0.188 0.051 0.000 1.092 1.207 1.336
Nationality (ref: non‐Dutch) −0.818 0.215 0.000 0.286 0.441 0.680
Pain intensity (NPRS) range 0–100 −0.011 0.004 0.010 0.981 0.989 0.997
Age (years) −0.009 0.004 0.031 0.982 0.991 0.999
Gender (ref: female) −0.214 0.111 0.055 0.649 0.807 1.004
Constant −0.392 0.762 0.608 0.148 0.676 3.080
Abbreviation: CI, confidence interval; MPI, multidimensional pain inventory; NPRS, numeric pain rating scale; ODI, oswestry disability index; SE, standard error.
aCoefficient multivariable logistic regression 
T A B L E  3  Multivariate model using the top 20th percentile of societal costs as an outcome
 
Coefficient 
(regression)a
SE (regression 
coefficient) p‐value
95% CI
Lower bound Odds ratio Upper bound
Diagnosis (ref: sacroiliac joint)
Facet 0.053 0.113 0.640 0.841 1.054 1.322
Disc 0.355 0.722 0.624 0.342 1.426 5.954
Combined 0.280 0.110 0.013 1.063 1.323 1.649
Unclear 0.297 0.378 0.433 0.638 1.346 2.843
Physical health (Rand−36); range 0–100 −0.056 0.014 0.000 0.919 0.946 0.973
Functional disability (ODI); range 0–100 0.028 0.007 0.000 1.015 1.028 1.043
Health‐related quality of life (EQ−5D−3L); 
range 0–100
−0.005 0.002 0.006 0.991 0.995 0.998
Impact of pain experience (MPI interfer-
ence) range 0–100
0.176 0.036 0.000 1.110 1.192 1.280
Nationality (ref: non‐Dutch) −0.948 0.226 0.000 0.244 0.388 0.616
Pain intensity (NPRS); range 0–100 −0.010 0.003 0.002 0.984 0.990 0.996
Gender (ref: female) −0.239 0.089 0.008 0.660 0.787 0.939
Constant −0.027 0.559 0.962 0.318 0.973 2.983
Abbreviation: CI, confidence interval; MPI, multidimensional pain inventory; NPRS, numeric pain rating scale; ODI, oswestry disability index; SE, standard error.
aCoefficient multivariable logistic regression. 
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costs and utilized health care more quickly than men and 
when men used health care for LBP it resulted in higher costs 
on average. The present study had almost double the amount 
of women compared to men, whereas there was a small dif-
ference in the amount of men and women in the study of 
Wenig et al. (2009).
Another important difference between the present study 
and the previous ones is the applied perspective. In the pres-
ent study, a societal perspective was applied, including health 
care, absenteeism, informal care and unpaid productivity 
costs, whereas Engel et al. (1996) and Ritzwoller et al. (2006) 
only included health care costs. Becker et al. (2010) evaluated 
costs from a societal perspective but did not include infor-
mal care costs, Wenig et al. (2009) also applied a societal ap-
proach that included health care and lost productivity costs, 
but did not include informal care costs.
Also important to note is the higher Nagelkerke's R2 for the 
model by Becker et al. (i.e. 0.28) compared to that of the present 
study (i.e. 0.14). Information regarding the fit of the model 
(Nagelkerke's R2, AUC) is missing from some previous studies 
(Engel et al., 1996; Wenig et al., 2009). In the present study, 
the explained variance was probably lower than that of other 
studies because we applied the broadest perspective, that is, the 
societal one. The relatively low explained variance may also be 
interpreted as the variables entered into our model are less suit-
able at predicting high costs (Ekman et al., 2005), important 
predictors are missing or chronic LBP patients who are hav-
ing high costs are a heterogeneous population. Demographic, 
social and clinical factors included in this model, as in other 
prediction studies, are typically measured in LBP studies.
Other predictive factors of high costs include diabetes, 
rheumatoid arthritis, back pain persistence (Engel et al., 
1996), fear of avoidance beliefs (Becker et al., 2010), low ed-
ucation and unemployment (Wenig et al., 2009). In contrast 
to our findings, both low education level and unemployment 
were not predictors of high costs in our sensitivity analysis, 
T A B L E  4  Multivariate model using the top 5th percentile of societal costs as an outcome
 
Coefficient 
(regression)a
SE (regression 
coefficient) p‐value
95% CI
Lower bound Odds ratio Upper bound
Education (ref: low)
Medium 0.099 0.201 .626 0.738 1.104 1.650
High 0.396 0.227 .086 0.940 1.486 2.336
Physical health (Rand−36); range 0–100 −0.078 0.026 .004 0.878 0.925 0.974
Functional disability (ODI); range 0–100 0.041 0.011 0000 1.019 1.042 1.065
Health‐related quality of life 
(EQ−5D−3L); range 0–100
−0.008 0.003 .028 0.986 0.992 0.999
Impact of pain experience (MPI interfer-
ence) range 0–100
0.183 0.063 .004 1.061 1.201 1.359
Nationality (ref: non‐Dutch) −0.855 0.248 .001 0.259 0.425 0.697
Pain intensity (NPRS); range 0–100 −0.013 0.006 .023 0.975 0.987 0.998
Constant −1.413 0.904 .121 0.040 0.243 1.463
Abbreviation: CI, confidence interval; MPI, multidimensional pain inventory; NPRS, numeric pain rating scale; ODI, oswestry disability index; SE, standard error.
aCoefficient multivariable logistic regression 
T A B L E  5  Robust predictors of high societal costs in all three models
 
Top 10th percentile Top 20th percentile Top 5th percentile
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
Physical health (Rand − 36); range 0–100 0.933 (0.895–0.973) 0.946 (0.919–0.973) 0.926 (0.878–0.976)
Functional disability (ODI); range 0–100 1.036 (1.019–1.053) 1.028 (1.015–1.043) 1.041 (1.018–1.063)
Health‐related quality of life (EQ−5D−3L); range 
0–100
0.994 (0.989–1.000) 0.995 (0.991–0.998) 0.992 (0.985–0.999)
Impact of pain experience (MPI interference) range 
0–100
1.017 (1.008–1.027) 1.016 (1.010–1.016) 1.017 (1.005–1.028)
Nationality (ref: non‐Dutch) 0.441 (0.286–0.680) 0.388 (0.244–0.616) 0.424 (0.258–0.698)
Pain intensity (NPRS); range 0–100 0.989 (0.981–0.997) 0.990 (0.984–0.996) 0.987 (0.976–0.998)
Abbreviation: CI, confidence interval; MPI, multidimensional pain inventory; NPRS, numeric pain rating scale; ODI, oswestry disability index.
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but high education level was. A possible explanation for this 
is that, 86% of the patients included in this study had compre-
hensive health care insurance. Highly educated persons are 
likely to afford more expensive and comprehensive insurance 
packages offering more options for health care and visits to 
alternative medicine and therapies. This finding has import-
ant implications for the understanding of the relation between 
socio‐economic status and high‐cost users in chronic LBP. In 
addition, for interventions and policies aimed at highly edu-
cated high‐cost users in LBP.
In the present study, the average societal costs per patient 
were €5,522, whereas Dutmer et al (2019) reported around 
€9,000 in societal costs per patient (Dutmer et al., 2019). This 
difference could have resulted from the absence of presentee-
ism costs in the present study, whereas Dutmer et al (2019) did 
include this cost category in their societal cost estimation. As a 
consequence, some productivity costs may have been missed. In 
addition, only patients from a secondary setting were included 
in the present study, whereas Dutmer et al (2019) included 
patients from both secondary and tertiary settings. Tertiary 
settings are generally more costly compared to secondary set-
tings. Moreover, Dutmer et al (2019) reported higher levels of 
disability than were reported in the present study, while high 
levels of disability are typically associated with high costs in 
LBP (Hartvigsen et al., 2001; Lambeek et al., 2011).
4.3 | Strength and limitations
Strengths of the present study include that it was one of the 
very few studies to identify predictive factors for high costs 
in patients with chronic LBP and that the societal perspec-
tive was applied. The large cohort of observed patients with 
chronic LBP (n = 6,316) greatly increases the power of this 
study and improves sensitivity to weak predictive factors. 
Imputation methods were used to deal with missing data 
thereby avoiding complete‐case analysis which would have 
significantly reduced the power of these findings and poten-
tially introduced information bias due to selective drop‐out 
of participants. Multiple imputation is the preferred statistical 
method for dealing with missing data, particularly when costs 
are involved (Burton et al., 2007). Furthermore, internally 
validating the model by bootstrapping with 250 replications 
improved the generalizability and robustness of these find-
ings (Bewick et al., 2005; Steyerberg et al., 2013).
Some limitations are notable as well. Although mainly 
valid and reliable questionnaires were used, the predictive 
factors were measured using self‐reported questionnaires 
and this might have caused recall and or social desirability 
bias. Second, presenteeism costs were not included in our 
analyses, whereas presenteeism has previously been found 
to be a very important cost driver and is increasingly being 
recognized as an important problem in the occupational set-
ting (Tsuboi, Murata, Naruse, & Ono, 2019). Hence, further 
productivity losses could have been missed. Future studies 
should therefore include presenteeism costs. Third, there is 
no consensus regarding the most ideal cut‐off point for de-
fining high costs. Although in this study different cut‐off 
points, that is, 10% (≥€11,922), 5% (≥€19,403) and 20% 
(≥€7,906), were used to assess the robustness of the model, 
a consensus should be reached on the definition of high 
costs. This will enable the results to be more comparable and 
also determine the most suitable moment for initiatives aim-
ing to reduce these costs to be applied. Fourth, in spite of the 
relatively large sample size of the current study (n = 6,316), 
there were some predictive factors for which there were very 
few participants. For example, there were only four (2.8%) 
non‐Dutch nationals in the high‐cost group in the main anal-
ysis, and it is unknown whether these four participants are 
representative of all non‐Dutch LBP patients. As a conse-
quence, even though non‐Dutch nationality was identified 
as a predictor in all of the models, further research is needed 
to establish whether non‐Dutch nationality is indeed a very 
strong predictor of having high societal costs among LBP 
patients. Fifth, the secondary care setting of this study may 
to some extent limit the generalizability of its findings to 
other types of LBP patients and/or other settings. Amongst 
others, the relatively high unemployment rate of 59% may 
have resulted in an underestimation of the productivity 
costs, whereas secondary care is generally more expensive 
than primary care and health care costs may thus have been 
overestimated (Lambeek et al., 2011). As a consequence, the 
total societal cost estimates are likely to be specific to the 
secondary care setting. Furthermore, the disability rate in 
this study is rather low in comparison to other studies con-
ducted in secondary settings (Dutmer et al., 2019), there-
fore caution should be exercised when applying these results 
to other populations. Sixth, apart from high BMI‐related 
diseases no other comorbidities have been included in the 
study. Overweight and obesity are well represented in the 
present study because these were exclusion criteria for the 
RCTs in the Mint study.
4.4 | Implications for research and practice
The lack of professional consensus regarding a cut‐off point 
for high costs is probably due to limited studies in this field. 
Having a consensus regarding a cut‐off point can enable 
comparisons to be made and it is essential in policy and deci-
sion making. Identifying those patients who are at risk (risk 
stratification) of becoming high‐cost users and making ap-
propriate initiatives could help in reducing high costs. For 
example, non‐Dutch nationality might be associated with a 
more limited mastery of the language. Maybe the information 
provided to non‐Dutch patients should be adapted. Functional 
disability and poor physical health are predictors of high so-
cietal costs, therapies targeting limitations in activities could 
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play a role in reducing societal costs. There is evidence from 
randomized controlled trials that stratified care models limit 
long‐term disability arising from LBP (Linton, Nicholas, & 
Shaw, 2018). These considerations have important implica-
tions for how the link between socio‐economic status and 
high‐cost use is understood and for policies and programs 
targeting high‐cost use.
5 |  CONCLUSION
The present study identifies patients at risk of becoming high‐
cost users and future studies should focus on understanding 
the mechanisms associated with the identified predictors for 
high‐cost users in order to be able to design and tailor effec-
tive cost reduction initiatives.
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